Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases

doi:10.1007/s13167-011-0075-0

. 2011 Mar;2(1):1-4.

doi: 10.1007/s13167-011-0075-0. Epub 2011 Apr 7.

Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases

Hiroyasu Iso¹

Affiliations

Affiliation

¹ Professor of Public Health, Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadagaoka, Suita-shi, Osaka, 565-0871 Japan.

PMID: 23199122
PMCID: PMC3405364
DOI: 10.1007/s13167-011-0075-0

Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases

Hiroyasu Iso. EPMA J. 2011 Mar.

. 2011 Mar;2(1):1-4.

doi: 10.1007/s13167-011-0075-0. Epub 2011 Apr 7.

Author

Hiroyasu Iso¹

Affiliation

¹ Professor of Public Health, Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadagaoka, Suita-shi, Osaka, 565-0871 Japan.

PMID: 23199122
PMCID: PMC3405364
DOI: 10.1007/s13167-011-0075-0

No abstract available

PubMed Disclaimer

Figures

**Fig. 1**
Map showing the countries of the contributors to the editorial and review articles in the current journal issue

See this image and copyright information in PMC

Cited by

Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016.
Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, Krapfenbauer K, Mozaffari MS, Costigliola V. Golubnitschaja O, et al. EPMA J. 2016 Oct 25;7(1):23. doi: 10.1186/s13167-016-0072-4. eCollection 2016. EPMA J. 2016. PMID: 27800037 Free PMC article. Review. No abstract available.
EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements.
Golubnitschaja O, Costigliola V; EPMA. Golubnitschaja O, et al. EPMA J. 2015 Feb 24;6(1):4. doi: 10.1186/s13167-015-0026-2. eCollection 2015. EPMA J. 2015. PMID: 25878761 Free PMC article.
Personalized approach of medication by indirect anticoagulants tailored to the patient-Russian context: what are the prospects?
Belozerceva LA, Voronina EN, Kokh NV, Tsvetovskay GA, Momot AP, Lifshits GI, Filipenko ML, Shevela AI, Vlasov VV. Belozerceva LA, et al. EPMA J. 2012 Sep 27;3(1):10. doi: 10.1186/1878-5085-3-10. EPMA J. 2012. PMID: 23016735 Free PMC article.
Changes in the triglyceride-glucose-body mass index estimate the risk of hypertension among the middle-aged and older population: a prospective nationwide cohort study in China in the framework of predictive, preventive, and personalized medicine.
Zhang M, Guan Q, Guo Z, Guan C, Jin X, Dong H, Tang S, Hou H. Zhang M, et al. EPMA J. 2024 Oct 8;15(4):611-627. doi: 10.1007/s13167-024-00380-6. eCollection 2024 Dec. EPMA J. 2024. PMID: 39635021
Predictive and preventive strategies to advance the treatments of cardiovascular and cerebrovascular diseases: the Ukrainian context.
Lushchyk UB, Novytskyy VV, Babii IP, Lushchyk NG, Riabets LS. Lushchyk UB, et al. EPMA J. 2012 Oct 19;3(1):12. doi: 10.1186/1878-5085-3-12. EPMA J. 2012. PMID: 23083430 Free PMC article.

References

1. Rosolova H, Nussbaumerova B. Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases. EPMA J. 2011 - PMC - PubMed
1. Colley KJ, Wolfert RL, Cobble ME. Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk. EPMA J. 2011 - PMC - PubMed
1. Miura K. Epidemiology and prevention of hypertension in Japanese: how could Japan get longevity? EPMA J. 2011 - PMC - PubMed
1. Yatsuya H, Yamagishi Y, Iso H. Adiposity and risk of cardiovascular diseases in Japan: secular trend, individual level associations and causal pathway – implications for the prevention of cardiovascular diseases in societies with rapid economic development. EPMA J. 2011 - PMC - PubMed
1. Kokubo Y. Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? EPMA J. 2011 - PMC - PubMed

LinkOut - more resources

Full Text Sources

[1] Rosolova H, Nussbaumerova B. Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases. EPMA J. 2011 - PMC - PubMed

[2] Rosolova H, Nussbaumerova B. Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases. EPMA J. 2011 - PMC - PubMed

[3] Colley KJ, Wolfert RL, Cobble ME. Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk. EPMA J. 2011 - PMC - PubMed

[4] Colley KJ, Wolfert RL, Cobble ME. Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk. EPMA J. 2011 - PMC - PubMed

[5] Miura K. Epidemiology and prevention of hypertension in Japanese: how could Japan get longevity? EPMA J. 2011 - PMC - PubMed

[6] Miura K. Epidemiology and prevention of hypertension in Japanese: how could Japan get longevity? EPMA J. 2011 - PMC - PubMed

[7] Yatsuya H, Yamagishi Y, Iso H. Adiposity and risk of cardiovascular diseases in Japan: secular trend, individual level associations and causal pathway – implications for the prevention of cardiovascular diseases in societies with rapid economic development. EPMA J. 2011 - PMC - PubMed

[8] Yatsuya H, Yamagishi Y, Iso H. Adiposity and risk of cardiovascular diseases in Japan: secular trend, individual level associations and causal pathway – implications for the prevention of cardiovascular diseases in societies with rapid economic development. EPMA J. 2011 - PMC - PubMed

[9] Kokubo Y. Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? EPMA J. 2011 - PMC - PubMed

[10] Kokubo Y. Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? EPMA J. 2011 - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases

Affiliation

Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases

Author

Affiliation

Figures

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources